Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.

SB 1812 limits health insurance prior authorizations for prescription drugs treating neurodegenerative diseases (like Alzheimer's or Parkinson's) to one per year per patient. It directly affects patients with these conditions who rely on ongoing prescription drug coverage. The bill amends insurance code to prohibit insurers from requiring more than one annual prior authorization for such treatments. This applies only to health benefit plans delivered, issued, or renewed on or after January 1, 2026. The law takes effect September 1, 2025.